Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes

scientific article (publication date: February 2005)

Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NG0205-110
P698PubMed publication ID15678135
15678137
15678134

P50authorThomas J. HudsonQ3525236
John A. ToddQ6217960
Dag UndlienQ17113394
Jaakko TuomilehtoQ28050079
David B. DungerQ40388857
Neil M WalkerQ44919496
Joanna HowsonQ55704445
Deborah SmythQ56436977
David P StrachanQ64858751
Kjersti S RønningenQ87133702
Cristian GujaQ87858483
Wendy L McArdleQ87944939
Alex K LamQ88560952
Constantin Ionescu-TirgovisteQ93049170
Sarah NutlandQ114721568
Rebecca C J TwellsQ117249563
Eva Tuomilehto-WolfQ117249577
Jayne HutchingsQ117249582
P2093author name stringDavid Savage
Andrew D Paterson
Xiao-Qing Liu
Christopher E Lowe
Bhupinder Bharaj
Constantin Polychronakos
Huiqi Qu
Joseph A Curtis
Leigh Anne Newhook
Sukyung Park
Yongsoo Park
Dukhee Kim
Seiwon Yang
Jungu Kang
P2860cites workA M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitusQ28259884
A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetesQ28268724
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetesQ28271534
Assessing the probability that a positive report is false: an approach for molecular epidemiology studiesQ29616285
Genome-wide association studies: theoretical and practical concernsQ34555195
Betting odds and genetic associations.Q52001328
P433issue2
P407language of work or nameEnglishQ1860
P921main subjecttype-1 diabetesQ124407
P304page(s)112; author reply 112-3
111-2; author reply 112-3
110-1; author reply 112-3
P577publication date2005-02-01
P1433published inNature GeneticsQ976454
P1476titleAssessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes
P478volume37

Reverse relations

cites work (P2860)
Q33587978Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes
Q33606764Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.
Q59697422Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease
Q28275909Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients
Q36666047Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations
Q37005340ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in Chinese
Q37088194From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.
Q36816687Genes mediating environment interactions in type 1 diabetes
Q36915466Genetic Basis of Type 1 Diabetes: Similarities and Differences between East and West
Q28275898Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene
Q43695619Genetic epidemiology of type 1 diabetes
Q39570426Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis
Q36666056Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations
Q42976544Is a new immune response mediator in the NF-kappaB pathway--SUMO-4--related to type 1 diabetes?
Q55044269Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.
Q33942274Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms
Q38206114Molecular mechanisms in autoimmune type 1 diabetes: a critical review.
Q51123079Network medicine analysis of chondrocyte proteins towards new treatments of osteoarthritis.
Q28293968No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients
Q56901681No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes
Q84906310Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes
Q33417956Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.
Q37148579Posttranslational Protein Modifications in Type 1 Diabetes - Genetic Studies with PCMT1, the Repair Enzyme Protein Isoaspartate Methyltransferase (PIMT) Encoding Gene
Q24538382Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4
Q34247327SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4.
Q57449327SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients
Q34008085SUMO4 and its role in type 1 diabetes pathogenesis
Q37034965Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.
Q43241836Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan
Q35637247Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus
Q38961119Sumoylation Modulates the Susceptibility to Type 1 Diabetes.
Q30437398The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Search more.